Benchmarking

Partner Content

Global benchmarking company STEM Healthcare (STEM) is pleased to announce the appointment of Jason McKenna as CEO.

Partner Content

Partner Content

STEM Marketing becomes STEM Healthcare

News

Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.